Gilead Sciences Balance Sheet Health
Financial Health criteria checks 3/6
Gilead Sciences has a total shareholder equity of $17.5B and total debt of $25.2B, which brings its debt-to-equity ratio to 144.3%. Its total assets and total liabilities are $56.3B and $38.8B respectively. Gilead Sciences's EBIT is $9.9B making its interest coverage ratio 17.7. It has cash and short-term investments of $6.1B.
Key information
144.3%
Debt to equity ratio
US$25.19b
Debt
Interest coverage ratio | 17.7x |
Cash | US$6.06b |
Equity | US$17.46b |
Total liabilities | US$38.84b |
Total assets | US$56.29b |
Recent financial health updates
These 4 Measures Indicate That Gilead Sciences (NASDAQ:GILD) Is Using Debt Reasonably Well
Nov 17We Think Gilead Sciences (NASDAQ:GILD) Can Stay On Top Of Its Debt
Aug 11Recent updates
We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s (NASDAQ:GILD) CEO Compensation
May 02Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is On The Mark
Apr 22Gilead Sciences: Some Signs Of An Impending Bottom
Apr 22Gilead Sciences: Realizing Financial Projections Is Key
Mar 20Gilead Sciences' (NASDAQ:GILD) Dividend Will Be Increased To $0.77
Mar 13Gilead's Business Development: The Good, The Bad, And The Spinning Kite Solution
Mar 01Gilead Sciences (NASDAQ:GILD) Has Announced That It Will Be Increasing Its Dividend To $0.77
Feb 28We Think Gilead Sciences' (NASDAQ:GILD) Solid Earnings Are Understated
Feb 15Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.77
Feb 13Gilead Sciences: Cheap For A Reason
Feb 10Gilead Sciences: The Sky Is Not Falling
Feb 01Does Gilead Sciences (NASDAQ:GILD) Deserve A Spot On Your Watchlist?
Jan 15What Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is Not Telling You
Dec 25These 4 Measures Indicate That Gilead Sciences (NASDAQ:GILD) Is Using Debt Reasonably Well
Nov 17Does Gilead Sciences (NASDAQ:GILD) Deserve A Spot On Your Watchlist?
Oct 10We Think Gilead Sciences (NASDAQ:GILD) Can Stay On Top Of Its Debt
Aug 11Financial Position Analysis
Short Term Liabilities: GILD's short term assets ($14.0B) exceed its short term liabilities ($13.0B).
Long Term Liabilities: GILD's short term assets ($14.0B) do not cover its long term liabilities ($25.8B).
Debt to Equity History and Analysis
Debt Level: GILD's net debt to equity ratio (109.6%) is considered high.
Reducing Debt: GILD's debt to equity ratio has increased from 120.3% to 144.3% over the past 5 years.
Debt Coverage: GILD's debt is well covered by operating cash flow (33.7%).
Interest Coverage: GILD's interest payments on its debt are well covered by EBIT (17.7x coverage).